Kavar Capital Partners Group’s Accendra Health ACH Stock Holding History

Kavar Capital Partners Group’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$1K	–	355
2019 Q2	$1K	Buy	+200	New	+$682	﹤0.01%	490

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kavar Capital Partners Group's ACH Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Accendra Health (ACH) in Q3 2019, closing a stake of 200 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in ACH in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 175 funds tracked by Wall St. Rank hold ACH as of Q3 2019.

Kavar Capital Partners Group reported no remaining Accendra Health position as of Q3 2019 after selling out during the quarter.
Kavar Capital Partners Group sold 200 Accendra Health shares in Q3 2019, an estimated $1K.
Kavar Capital Partners Group first reported a position in Accendra Health in Q2 2019 and held it in 1 quarter.
Kavar Capital Partners Group's Accendra Health position peaked at $1K in Q2 2019.
175 funds tracked by Wall St. Rank held Accendra Health as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.